Hot Products

2-Oxopomolic acid
Catalog No: CFN98920

2-Oxopomolic acid shows cytotoxic activity, it shows a significant decrease in intracellular melanin content in B16-F10 cells, and in culture media melanin. 2-Oxopomolic acid shows radical-scavenging activities similar to that of the reference antioxidant alpha-tocopherol (vitamin E).

2-Pentylfuran
Catalog No: CFN93061

2-Pentylfuran is a naturally occuring flavouring ingredient, it may be a biomarker for lung colonization/infection by fungal pathogens. 2-Pentylfuran and isomers of 2-pentenylfuran are known to be mainly responsible for the undesirable reversion flavor of soybean oil.

2S-Amino-3R-octadecanol
Catalog No: CFN00048

2S-Amino-3R-octadecanol inhibits cell proliferation,it is an antitumour agent.

3-(Hydroxymethyl)cyclopentanol
Catalog No: CFN99022

Reference standards.

3,19-Dihydroxy-6,23-dioxo-12-ursen-28-oic acid
Catalog No: CFN98299

Reference standards.

3,29-Dibenzoyl karounitriol
Catalog No: CFN90576

3,29-Dibenzoyl karounitriol is a natural product from Trichosanthes kirilowii Maxim.

3,29-O-Dibenzoyloxykarounidiol
Catalog No: CFN91175

3,3',4',5,6,7,8-heptamethoxyflavone
Catalog No: CFN95021

3,3',4',5,6,7,8-Heptamethoxyflavone(HMF) has neuroprotective, chemopreventive, anti-allergic, anti-inflammatory, immunomodulatory, anti-aging and photoprotective effects; it inhibits collagenase activity and induces type I procollagen synthesis in HDFn cells, and against nitric oxide (NO) carcinogenesis.

3,3'-Di-O-methylellagic acid 4'-glucoside
Catalog No: CFN90830

Reference standards.

3',4',5,5',6,7-Hexamethoxyflavone
Catalog No: CFN70332

5,6,7,3',4',5'-Hexamethoxyflavone(HMF) has anticancer activities, it inhibits growth of triple-negative breast cancer cells via suppression of MAPK and Akt signaling pathways and arresting cell cycle. HMF may potentiate Cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channel activities through both elevation of cAMP level and binding to CFTR protein pathways, HMF may be developed as a new drug in the therapy of CFTR-related diseases such as bronchiectasis and habitual constipation.